SEC Form 4 · accession 0001179110-16-027111
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manoj Maniar
Officer — SVP - Product Development
Period of report
Jun 30, 2016
Accepted (ET)
Jun 30, 2016 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2016 | M | 50 | $6.50 | A | 50 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $6.50 | Jun 30, 2016 | M | 50 | D | Jan 26, 2016 | Jan 26, 2026 | Common Stock | 50 | 10,342 | D |